At RMA-FL we understand that for some patients the path to pregnancy and a positive fertility experience sometimes requires a little help. With donor egg success rates among the highest in the US, the Ovatures Egg Donation Program anonymously provides potential egg donors the opportunity to help a couple build their family. It takes a special person to become an egg donor and requires a commitment of time, energy and compassion.
RMA-FL utilizes RMANJ’s unique, rapid and scientific method to improve the embryo selection process, called SelectCCS (Comprehensive Chromosome Screening). This one-of-a-kind 24-chromosome screening platform identifies whether embryos are euploid (normal number of chromosomes) or aneuploid (abnormal number of chromosomes). In 2013 RMANJ donated SelectCCS to the Foundation for Embryonic Competence (FEC), a non-profit organization dedicated to improving outcomes and advancing knowledge in the areas of research, diagnosis, and education. SelectCCS is owned and operated by the Foundation of Embryonic Competence.
RMA-FL celebrates the diversity of our center’s community. Our center is committed to treating all patients and prohibits discrimination against people on the basis of race, color, creed, religion, national origin, age, ability, sex, gender identity or expression, affectional or sexual orientation, marital statuses (including domestic partnerships and civil unions) or any other basis protected by federal, state, or local law. An RMA-FL initiative, the Ally Program supports the education of staff about what it means to be an ally in healthcare. The program takes action to support the LGBTQ patient community pursuing reproductive technologies.
Everyone has a story. Everyone has questions. FertiliTalk is the support network for fertility patients, by fertility patients. It’s a great way to share experiences, ask questions, learn from others, and know you are absolutely not alone on your fertility journey. FertiliTalk is sponsored by Reproductive Medicine Associates of Florida and is provided as a support resource only.
RMA-FL participates in national consumer-lending programs that can make financial resources available to couples at competitive rates. For treatments or services not covered by medical insurance, or for individuals or couples in need of financial assistance, Attain® IVF offers multiple treatment plans for a single, discounted fee that increases your chance of success.
RMA-FL participates in national consumer-lending programs that can make financial resources available to couples at competitive rates. For treatments or services not covered by medical insurance, or for individuals or couples in need of financial assistance, Advanced Reproductive Care, Inc. (ARC) offers a number of affordable options for patients to help maximize your opportunity for having a baby, while minimizing your financial risk.
The American Society for Reproductive Medicine (ASRM) is a multidisciplinary organization dedicated to the advancement of the ART (Assisted Reproductive Technologies), science, and practice of reproductive medicine. ASRM accomplishes its mission through the pursuit of excellence in education and research and through advocacy on behalf of patients, physicians, and affiliated health care providers. ASRM is committed to facilitating and sponsoring educational activities for the lay public and continuing medical education activities for professionals who are engaged in the practice of and research in reproductive medicine. As professionals in the field of reproductive endocrinology, RMA-FL’s physician and nursing professionals, along with many of our senior executive staff, are active members in the American Society for Reproductive Medicine.
The American Congress of Obstetricians and Gynecologists (ACOG) is a private, voluntary, nonprofit membership organization. As the premier organization for obstetrician and gynecologist professionals and providers of women’s health care, it provides the highest quality education worldwide, continuously improves health care for women through practice and research, leads advocacy for women’s health care issues nationally and internationally, and provides excellent organizational support and services for their members. As a commitment to excellence and continued growth, our RMA-FL physician is board certified in his field of expertise.
The Society for Assisted Reproductive Technology (SART) is the primary organization of professionals dedicated to the practice of assisted reproductive technologies (ART) in the United States. ART includes the practice of In Vitro Fertilization (IVF). The mission of SART is to set up and help maintain the standards for ART in an effort to better serve their members and patients. One of their most important functions is to help patients locate and contact infertility clinics and view national and individual clinic IVF success rates.
As the largest civil rights organization working to achieve equality for lesbian, gay, bisexual, and transgender Americans, the Human Rights Campaign represents a force of more than 1.5 million members and supporters nationwide — all committed to making HRC’s vision a reality. The Healthcare Equality Index (HEI) is a unique and invaluable resource, helping healthcare organizations to provide equitable, inclusive care to LGBTQ Americans—and for LGBTQ Americans seeking healthcare organizations with a demonstrated commitment to their care. The RMA network has been recognized as a “Leader in LGBTQ Healthcare Equality” in the Healthcare Equality Index since 2013, for our commitment to equitable, inclusive care for LGBTQ patients and their families, who can face significant challenges in securing adequate healthcare.
The Foundation for Embryonic Competence (FEC) (www.feclabs.org) is a non-profit organization dedicated to improving outcomes and advancing knowledge in the area of embryonic research, diagnosis, and education. The FEC has several missions in support of infertility patients and healthcare providers alike, including: Sponsoring cutting edge translational research into new embryo diagnostics that improve outcomes and reduce complications related to assisted reproductive technologies (ART). Providing access to well-validated, safe, and highly accurate embryo screening diagnostics that improve implantation and delivery rates. Providing access to single gene defect diagnostics to individual carriers of specific genetic disorders to reduce the transfer of potentially debilitating and life-long disease. Supporting continuing medical education (CME), graduate level educational initiatives, and other educational activities that advance our understanding of embryonic competence and increase access to embryonic testing for infertility patients.